114 related articles for article (PubMed ID: 28426833)
1. Correction: Modulation of behaviour and virulence of a high alginate expressing Pseudomonas aeruginosa strain from cystic fibrosis by oral commensal bacterium Streptococcus anginosus.
Waite RD; Qureshi MR; Whiley RA
PLoS One; 2017; 12(4):e0176577. PubMed ID: 28426833
[TBL] [Abstract][Full Text] [Related]
2. Modulation of behaviour and virulence of a high alginate expressing Pseudomonas aeruginosa strain from cystic fibrosis by oral commensal bacterium Streptococcus anginosus.
Waite RD; Qureshi MR; Whiley RA
PLoS One; 2017; 12(3):e0173741. PubMed ID: 28301571
[TBL] [Abstract][Full Text] [Related]
3. Differential potentiation of the virulence of the Pseudomonas aeruginosa cystic fibrosis liverpool epidemic strain by oral commensal Streptococci.
Whiley RA; Sheikh NP; Mushtaq N; Hagi-Pavli E; Personne Y; Javaid D; Waite RD
J Infect Dis; 2014 Mar; 209(5):769-80. PubMed ID: 24158959
[TBL] [Abstract][Full Text] [Related]
4. Correction: Within-host whole genome analysis of an antibiotic resistant Pseudomonas aeruginosa strain sub-type in cystic fibrosis.
Sherrard LJ; Tai AS; Wee BA; Ramsay KA; Kidd TJ; Ben Zakour NL; Whiley DM; Beatson SA; Bell SC
PLoS One; 2019; 14(1):e0210929. PubMed ID: 30640960
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathogenicity of Streptococcus anginosus.
Asam D; Spellerberg B
Mol Oral Microbiol; 2014 Aug; 29(4):145-55. PubMed ID: 24848553
[TBL] [Abstract][Full Text] [Related]
6. A commensal streptococcus hijacks a Pseudomonas aeruginosa exopolysaccharide to promote biofilm formation.
Scoffield JA; Duan D; Zhu F; Wu H
PLoS Pathog; 2017 Apr; 13(4):e1006300. PubMed ID: 28448633
[TBL] [Abstract][Full Text] [Related]
7. Genotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strains.
Varga JJ; Barbier M; Mulet X; Bielecki P; Bartell JA; Owings JP; Martinez-Ramos I; Hittle LE; Davis MR; Damron FH; Liechti GW; Puchałka J; dos Santos VA; Ernst RK; Papin JA; Albertí S; Oliver A; Goldberg JB
BMC Genomics; 2015 Oct; 16():883. PubMed ID: 26519161
[TBL] [Abstract][Full Text] [Related]
8. [Alginate, elastase and alkaline protease production of Pseudomonas aeruginosa strains isolated from various body sites].
Ciragil P; Söyletir G
Mikrobiyol Bul; 2004 Oct; 38(4):341-7. PubMed ID: 15700659
[TBL] [Abstract][Full Text] [Related]
9. Effect of estrogen on pseudomonas mucoidy and exacerbations in cystic fibrosis.
Chotirmall SH; Smith SG; Gunaratnam C; Cosgrove S; Dimitrov BD; O'Neill SJ; Harvey BJ; Greene CM; McElvaney NG
N Engl J Med; 2012 May; 366(21):1978-86. PubMed ID: 22607135
[TBL] [Abstract][Full Text] [Related]
10. Typing of Pseudomonas aeruginosa strains in Turkish cystic fibrosis patients.
Yagci A; Ciragil P; Over U; Sener B; Erturan Z; Soyletir G
New Microbiol; 2003 Jan; 26(1):109-14. PubMed ID: 12578318
[TBL] [Abstract][Full Text] [Related]
11. Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection.
Coleman FT; Mueschenborn S; Meluleni G; Ray C; Carey VJ; Vargas SO; Cannon CL; Ausubel FM; Pier GB
Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1949-54. PubMed ID: 12578988
[TBL] [Abstract][Full Text] [Related]
12. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis.
Pedersen SS
APMIS Suppl; 1992; 28():1-79. PubMed ID: 1449848
[TBL] [Abstract][Full Text] [Related]
13. Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis.
Ramsey DM; Wozniak DJ
Mol Microbiol; 2005 Apr; 56(2):309-22. PubMed ID: 15813726
[TBL] [Abstract][Full Text] [Related]
14. Immunological evaluation of an alginate-based conjugate as a vaccine candidate against Pseudomonas aeruginosa.
Farjah A; Owlia P; Siadat SD; Mousavi SF; Ardestani MS; Mohammadpour HK
APMIS; 2015 Feb; 123(2):175-83. PubMed ID: 25470757
[TBL] [Abstract][Full Text] [Related]
15. Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model.
Bragonzi A; Worlitzsch D; Pier GB; Timpert P; Ulrich M; Hentzer M; Andersen JB; Givskov M; Conese M; Doring G
J Infect Dis; 2005 Aug; 192(3):410-9. PubMed ID: 15995954
[TBL] [Abstract][Full Text] [Related]
16. Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice.
Hoffmann N; Lee B; Hentzer M; Rasmussen TB; Song Z; Johansen HK; Givskov M; Høiby N
Antimicrob Agents Chemother; 2007 Oct; 51(10):3677-87. PubMed ID: 17620382
[TBL] [Abstract][Full Text] [Related]
17. Pseudomonas aeruginosa and cystic fibrosis: unusual bacterial adaptation and pathogenesis.
Govan JR; Harris GS
Microbiol Sci; 1986 Oct; 3(10):302-8. PubMed ID: 3155268
[TBL] [Abstract][Full Text] [Related]
18. Community Composition Determines Activity of Antibiotics against Multispecies Biofilms.
Tavernier S; Crabbé A; Hacioglu M; Stuer L; Henry S; Rigole P; Dhondt I; Coenye T
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696232
[TBL] [Abstract][Full Text] [Related]
19. The fibronectin-binding protein homologue Fbp62 of Streptococcus anginosus is a potent virulence factor.
Kodama Y; Ishikawa T; Shimoyama Y; Sasaki D; Kimura S; Sasaki M
Microbiol Immunol; 2018 Oct; 62(10):624-634. PubMed ID: 30192020
[TBL] [Abstract][Full Text] [Related]
20. Gallium induces the production of virulence factors in Pseudomonas aeruginosa.
García-Contreras R; Pérez-Eretza B; Lira-Silva E; Jasso-Chávez R; Coria-Jiménez R; Rangel-Vega A; Maeda T; Wood TK
Pathog Dis; 2014 Feb; 70(1):95-8. PubMed ID: 24151196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
